Multiple Sclerosis Among Ills Highlighted at US Paralyzed Veterans’ Meet

Real Men Wear Gowns: Hepatitis C
September 7, 2016
Zero Alcohol Policy
September 7, 2016
Show all

Multiple Sclerosis Among Ills Highlighted at US Paralyzed Veterans’ Meet

A summit hosted by the Paralyzed Veterans of America in Florida brought together multiple sclerosis experts.

Paralyzed Veterans of America recently held its annual health conference, called 2016 Summit + EXPO, focused on the latest research and discoveries in patient care for diseases that span multiple sclerosis and spinal cord injury or disease to  amyotrophic lateral sclerosis.

This year was the sixth such summit, held Aug. 30–Sept. 1 in Orlando, Florida, and brought together 840 healthcare professionals from different disciplines to learn more about the scientific advances, and treatments and therapies in these disease areas of concern to U.S. veterans.

“Paralyzed Veterans of America is the only veterans’ organization to host a health summit of this kind and we are very proud of that,” said Lana McKenzie, the group’s associate executive director of Medical Services and Health Policy, in a news release. “Our goal is to ensure that health care providers who work in specialty care fields such as spinal cord injury and disease have the most up-to-date information in research and best practices so they can bring that information back to their respective hospitals and immediately put it to use to improve the care of their patients.”

More than 23 E-learning posters and 75 sessions were showcased at the event, with attendees having the opportunity to earn up to 23 Continuing Education Units while hearing from medical, policy and government experts.

Read Full Article: Multiple Sclerosis Among Ills Highlighted at US Paralyzed Veterans’ Meet

Read Full Article: Multiple Sclerosis Among Ills Highlighted at US Paralyzed Veterans’ Meet

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.